United States · FDA National Drug Code directory
Nuvicare Headache Relief
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 84324-007_88a74471-1213-445d-b5b9-937fcc520b91
- Product NDC
- 84324-007
- Form
- TABLET
- Composition / generic term
- ACETAMINOPHEN, Aspirin, Caffeine
- Labeler
- NUVICARE LLC
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20240717
- Source listing expiry
- 20261231
Source-listed ingredients
- CAFFEINE — 65 mg/1
- ACETAMINOPHEN — 250 mg/1
- ASPIRIN — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (84324-007-01) · 84324-007-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →